Indaptus to present Decoy10 data at AACR showing immune activation

Indaptus Therapeutics, Inc.

CSO Michael Newman to present Decoy10 poster at AACR 2024 in San Diego on April 10.
Data confirm mechanism of action: Decoy bacteria activate M1 macrophages, NK, dendritic, Th1 CD4, and CD8 T cells.
Abstract published in AACR journal Cancer Research to support the findings.

item 8.01

Indaptus Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-011080

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.